CION Ameerpet
Kidney Cancer · Treatment & Modalities
Partial vs radical nephrectomy — how the choice is actually made
Almost everyone told they need kidney surgery asks the same question first: will I lose the whole kidney? The choice between partial vs radical nephrectomy — kidney sparing vs full removal — is not a preference or a philosophy. It is a technical judgement made from your scan, your kidney function and where exactly the tumour sits. This page explains what pushes the decision each way, so you can follow the conversation and ask the right questions before anything is signed.
- Small and on the outside of the kidney — NCCN guidance treats kidney-sparing surgery as the standard approach for small tumours still confined to the kidney, wherever it can be done safely.
- Large, central or into the vein — removing the whole kidney is usually the more complete operation, and in that situation it is also the safer one.
- Your kidney function is half the argument — one kidney, tumours in both, diabetes, long-standing high blood pressure or existing kidney disease all push hard towards saving tissue.
- How CION works — the tumour board review, imaging read and kidney-function monitoring are in-house; the operation itself is coordinated with specialist urology and uro-oncology partners and may be billed at the partner centre.
17+
Cancer Specialists
on Panel
on Panel
35+
Centres across
Telangana & AP
Telangana & AP
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Before the decision
The two operations, in plain terms
A partial nephrectomy takes the tumour. A radical nephrectomy takes the kidney. In kidney-sparing surgery the surgeon removes the tumour with a rim of normal tissue around it, closes the raw surface of the kidney and leaves the rest of that kidney in place, still working. In a radical nephrectomy the whole kidney comes out, usually inside the envelope of fat around it, with nearby lymph nodes or the adrenal gland taken only where there is a specific reason. Both operations can be performed open, through keyhole ports or with robot assistance — that is the approach, and it is a separate question from how much kidney is removed.
Both operations have the same first aim. Neither is a compromise version of the other: the surgeon is trying to remove the tumour completely, with clear margins, in one piece. What separates them is the amount of working kidney tissue you keep, and that is why the question matters years later rather than only in the recovery ward. Kidneys filter, balance salts and fluid, control blood pressure and support red-cell production. Tissue that is removed does not grow back, so every decision to remove more of it is a decision about the rest of your life, not just the operation.
Where CION sits in this. Kidney surgery of every kind — partial, radical, keyhole, robot-assisted — is coordinated for CION patients with specialist urology and uro-oncology partners, and the surgical episode may be billed at that partner centre. What we do in-house is the part that decides the plan and follows it: reviewing the CT or MRI, checking kidney function, taking the case to a uro-oncology tumour board, arranging genetic counselling where an inherited pattern is suspected, and running the surveillance, systemic therapy or radiation that may come afterwards. Where a tumour is small, ablation is another coordinated option, arranged with interventional radiology. The full picture of what is delivered in-house and what is coordinated is set out on our kidney cancer treatment in Hyderabad page.
The question is not always “which operation”. For a very small tumour, especially in an older person or someone with other serious illness, careful monitoring — active surveillance — can be a legitimate third answer, and ablation a fourth. Ask which options were considered and why they were set aside, not only which one is being proposed. The wider map of the condition, from types and stages to symptoms and risk factors, is on our complete kidney cancer guide; this page stays with the one decision in front of you.
Four questions get you most of the way into that conversation:
- How big is the tumour, and where exactly does it sit? Ask whether it bulges out from the surface or is buried near the vessels and the collecting system. That single answer explains most recommendations.
- What is my kidney function now, and what is it likely to be afterwards? Ask for the actual numbers before surgery, so there is something to compare against later.
- Is a partial technically possible here — and if it is, why is it not being offered? A straight answer is reasonable to expect, and it is usually about position rather than about you.
- What happens if the plan has to change during the operation? Surgeons occasionally start a partial and finish a radical. Knowing that in advance is far better than hearing it afterwards.
If an operation has been proposed and nobody has explained the alternative, that is worth an hour with an oncologist. Book a free consultation and bring the scan report you already have.
Not every small kidney tumour turns out to be cancer
Up to a third of small kidney masses are benign — tumours such as oncocytoma and fat-containing angiomyolipoma are found on scans that were done for something else entirely. That is one reason a needle biopsy is sometimes taken before surgery: not because anyone doubts the plan, but because the result can occasionally change it. It is a fair question to ask before you agree to any operation on a kidney.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
This is not a decision to take in a corridor
Every kidney case at CION is read at a uro-oncology tumour board before an operation is recommended — a team reading, not one doctor’s first impression. Free first consultation, and no commitment to proceed.
The deciding factors
What pushes the decision towards sparing — and what pushes it the other way
Read this to follow the conversation you are about to have, not to decide your own operation. These factors are weighed together, and only a team that has seen your scan, your kidney function and you can put them in order.
| What is being weighed | Points towards keeping the kidney | Points towards removing it |
|---|---|---|
| Tumour size | Small tumours still confined to the kidney. NCCN guidance treats kidney-sparing surgery as the standard approach for these where it is technically feasible; 4 cm or less is the T1a category, and many tumours up to 7 cm are still considered. | Tumours well beyond 7 cm, where too little healthy kidney would remain to be worth reconstructing. |
| Where the tumour sits | Exophytic tumours — bulging out from the surface, away from the vessels and the collecting system, so the surgeon can cut around them with a clear margin. | Endophytic or hilar tumours — buried inside the kidney or hugging the vessels, where a safe reconstruction may not be possible. Surgeons often score this formally from the CT. |
| The other kidney | A solitary functioning kidney, or a second kidney that is diseased, shrunken or already carrying a tumour. Here sparing tissue is close to imperative. | A completely healthy second kidney with good function, which gives more room to remove the affected one safely. |
| Your baseline kidney function | Reduced function already, or diabetes, long-standing high blood pressure or known kidney disease — anything that shrinks the reserve you would be left with. | Normal function with no risk factors, where the remaining kidney has room to take over the work. |
| More than one tumour, or an inherited pattern | Tumours in both kidneys, several in one kidney, or an inherited syndrome where more tumours are expected over a lifetime. Every operation has to leave something for the next one, and genetic counselling is offered in-house. | A single tumour with no family pattern and no syndrome features, where one definitive operation is likely to be the end of it. |
| Vein, fat or node involvement | Nothing beyond the kidney on the scan and clean-looking fat around the tumour. | Tumour growing into the renal vein or the vena cava, spreading into the fat around the kidney, or clearly involved lymph nodes — all of which make removing the whole kidney the more complete operation. |
| The recovery you are facing | A keyhole or robot-assisted partial in experienced hands, where preserved function is worth the more demanding repair. | Frailty or serious heart or lung disease, where the shorter, simpler operation is the kinder one. Where surgery of any kind is too much, ablation or active surveillance may be discussed instead. |
| What the pathology report says afterwards | Clear margins on the removed tumour, which is what the surgeon is aiming for and what the report is checked for first. | A margin involved by tumour does not automatically mean more surgery — it usually means closer imaging follow-up, decided at the tumour board with the grade and stage in front of it. |
Neither operation is a lesser version of the other. Read partial nephrectomy (kidney-sparing surgery) and radical nephrectomy (removing the whole kidney) for what each involves on the day and in the weeks afterwards.
Honest trade-offs
What each operation costs you, and what it buys
Both operations are done well every day. The point of listing the trade-offs is so the recommendation you are given makes sense, not so you can argue with it.
Kidney sparing
Partial nephrectomy
What it buys. Working kidney tissue that you keep for life. For tumours that are small and still inside the kidney, guidelines treat cancer control after a complete kidney-sparing removal as comparable to taking the whole kidney, provided the margins come back clear.
- The more demanding operation, and the more experience-dependent one.
- More risk of bleeding, and of urine leaking from the repaired kidney in the days afterwards.
- The margin line on the pathology report is read closely, and occasionally changes the follow-up plan.
- Sometimes started and converted to a radical during surgery if the tumour proves harder than the scan suggested.
Full removal
Radical nephrectomy
What it buys. A single, complete removal of the tumour with the kidney around it — the more definitive operation when the tumour is large, central, or reaching into the fat or the vein.
- Avoids the reconstruction, so it avoids the problems that come with repairing a kidney.
- Leaves you with one kidney and less reserve if that kidney is ever stressed.
- Reduced kidney function afterwards matters most to people who already have diabetes, high blood pressure or kidney disease.
- Blood pressure, blood sugar, hydration and certain over-the-counter painkillers all need more attention afterwards.
What neither operation changes. Follow-up is set by what the pathology report shows — the subtype, the grade and the stage — not by which operation was done. That follow-up, and any treatment that may be needed afterwards, is delivered in-house at CION: surveillance scans and kidney-function checks, adjuvant immunotherapy of the checkpoint-inhibitor class where the features are higher risk, targeted or immunotherapy classes where disease is beyond the kidney, and focused radiation for specific problem sites. Which class applies to which situation is explained on our kidney cancer treatment in Hyderabad page.
The approach and the operation are two different questions
People often hear robotic and assume it means the kidney will be saved. It does not. Open, keyhole and robot-assisted describe how the surgeon gets to the kidney; partial and radical describe how much is removed once there. A radical can be done robotically and a partial can be done open. Ask both questions separately — and note that robot-assisted and keyhole kidney surgery are coordinated with specialist partner centres rather than delivered in-house at CION.
From scan to plan
How the decision is actually reached
None of this should happen in a hurry, and none of it should be decided without being explained to you first.
The scan is read properly, not glanced at
A dedicated contrast CT of the kidneys — or an MRI where contrast is a problem — shows the size of the tumour, whether it bulges out or sits buried, how close it is to the vessels and the collecting system, and whether anything is growing into the vein. This imaging review is done in-house. Where staging questions remain, PET-CT can be arranged, coordinated with a partner imaging centre.
Your kidney function is measured before anything is planned
Blood tests establish where your function starts from, and the scan shows how healthy the other kidney looks. This is not a formality: it is the number that decides how much weight the argument for sparing tissue carries. Diabetes, long-standing high blood pressure and existing kidney disease all count here.
A biopsy is considered — sometimes
A needle biopsy is not needed before every kidney operation, because the imaging appearance of some tumours is characteristic enough to act on. It is worth discussing when the mass is small, when surveillance or ablation are genuinely on the table, or when an unusual diagnosis would change the plan. Ask whether one would change anything in your case.
The case goes to a uro-oncology tumour board
Medical, surgical and radiation oncologists, with radiology input, read the imaging, the kidney function and any biopsy together, and agree what to recommend and why. A team reading rather than one doctor’s opinion, and it is how every kidney case at CION is handled before an operation is proposed.
The operation is scheduled with a specialist surgical partner
Kidney surgery — partial or radical, open, keyhole or robot-assisted — is coordinated with specialist urology and uro-oncology partners and may be billed at that partner centre. You should be told which operation is planned, which approach, who is operating, and what the plan is if the tumour proves harder than the scan suggested.
The pathology report sets everything that follows
After surgery the subtype, grade, stage and margin status decide the follow-up schedule and whether any treatment after surgery is discussed at all. That part comes back in-house — surveillance scans, kidney-function monitoring and, where it is needed, systemic therapy by drug class or focused radiation.
One thing worth raising yourself. If there are tumours in both kidneys, more than one tumour in the same kidney, a diagnosis at a young age or kidney cancer running in the family, ask whether genetic counselling is appropriate before surgery, not after. It is offered in-house at CION, and it can change how much kidney a surgeon tries to preserve — because it changes what the next twenty years may ask of that kidney.
Take the first step
Ask whether your kidney can be saved — before the date is booked
Every case at CION goes to a tumour board, not one doctor’s opinion. Bring the scan you have and we will go through it with you in 45 unhurried minutes.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Questions people ask about choosing between the two operations
What is the difference between a partial and a radical nephrectomy?
A partial nephrectomy, also called kidney-sparing surgery, removes the tumour with a rim of normal tissue around it and leaves the rest of that kidney in place and working. A radical nephrectomy removes the whole kidney, usually with the fat around it, and sometimes nearby lymph nodes or the adrenal gland when there is a specific reason to take them. Both can be done through open, keyhole or robot-assisted approaches, and both have the same first aim: to remove the tumour completely, with clear margins. What differs is how much working kidney tissue is left behind afterwards, and most of the decision turns on that.
Is a partial nephrectomy always better than removing the whole kidney?
No. It is preferred where it can be done safely, because keeping working kidney tissue protects long-term kidney function, and NCCN guidance treats kidney-sparing surgery as the standard approach for small tumours still confined to the kidney. But it is the more demanding operation. When the tumour is large, sits deep in the centre of the kidney, involves the collecting system or the renal vein, or when a safe reconstruction is not possible, removing the whole kidney is the more complete and often the safer operation. Sparing kidney tissue at the cost of leaving tumour behind helps nobody.
What decides whether my kidney can be saved?
Four things, weighed together. The tumour: how large it is, and whether it sits on the surface of the kidney or buried near the vessels and the collecting system, which surgeons often score formally from the CT. Your kidney function: your blood tests and how well the other kidney is working. Your own situation: a single functioning kidney, tumours in both kidneys, diabetes, long-standing high blood pressure, existing kidney disease or an inherited syndrome all push strongly towards saving tissue. And the operation itself: whether a partial can be completed safely with clear margins. For CION patients that assessment is made with our specialist urology and uro-oncology partners.
Can I live normally with one kidney after a radical nephrectomy?
Most people can. A single healthy kidney takes over much of the work of two, and people live full lives with one - living kidney donors do exactly that. What changes is your margin for error. Kidney function is checked before surgery and monitored afterwards, and blood pressure, blood sugar, hydration and certain over-the-counter painkillers matter more than they did before. If your kidney function was already reduced, or you have diabetes or long-standing high blood pressure, that reserve is smaller, which is precisely why those conditions push the discussion towards kidney-sparing surgery wherever it is feasible.
Does keeping part of the kidney make the cancer more likely to come back?
For tumours that are small and still inside the kidney, guidelines treat cancer control after a complete kidney-sparing removal as comparable to taking the whole kidney, provided the margins come back clear. The trade-offs sit elsewhere. A partial nephrectomy carries more risk of bleeding and of urine leaking from the repaired kidney in the days after surgery, and the margin line on the pathology report is read closely. A radical nephrectomy avoids those particular problems but leaves you with one kidney. Neither operation removes the need for follow-up scans, which are set by the stage and grade in the final pathology report.
Who decides, and can I get a second opinion before kidney surgery?
The recommendation should come from a tumour board rather than one person - medical, surgical and radiation oncologists reading your scans, your kidney function and, where one was taken, your biopsy together. You should be told which operation is proposed, why the other was set aside, and what happens if the surgeon has to change plan during the operation. A second opinion before kidney surgery is normal and reasonable. It is worth asking for when a partial is described as borderline, when the tumour is small enough that surveillance or ablation may also be options, or when the plan and the scan do not seem to agree.
This page is general health information about kidney cancer surgery. It is not a diagnosis and it cannot replace a specialist review of your own scans, blood results and medical history. Whether a kidney can be spared depends on findings that only a team who has examined your imaging and you can weigh. Kidney surgery, robot-assisted and keyhole approaches, tumour ablation and PET-CT are coordinated with specialist urology, uro-oncology and interventional-radiology partners and may be billed at the partner centre. If an operation has been proposed and you do not understand why, ask us before you agree to it.